418 related articles for article (PubMed ID: 25172387)
1. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury.
Morciano G; Giorgi C; Bonora M; Punzetti S; Pavasini R; Wieckowski MR; Campo G; Pinton P
J Mol Cell Cardiol; 2015 Jan; 78():142-53. PubMed ID: 25172387
[TBL] [Abstract][Full Text] [Related]
2. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.
Townsend PA; Davidson SM; Clarke SJ; Khaliulin I; Carroll CJ; Scarabelli TM; Knight RA; Stephanou A; Latchman DS; Halestrap AP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H928-38. PubMed ID: 17483234
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury.
Ong SB; Samangouei P; Kalkhoran SB; Hausenloy DJ
J Mol Cell Cardiol; 2015 Jan; 78():23-34. PubMed ID: 25446182
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection.
Bernardi P; Di Lisa F
J Mol Cell Cardiol; 2015 Jan; 78():100-6. PubMed ID: 25268651
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial permeability transition pore-dependent necrosis.
Robichaux DJ; Harata M; Murphy E; Karch J
J Mol Cell Cardiol; 2023 Jan; 174():47-55. PubMed ID: 36410526
[TBL] [Abstract][Full Text] [Related]
6. Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes.
Abdallah Y; Kasseckert SA; Iraqi W; Said M; Shahzad T; Erdogan A; Neuhof C; Gündüz D; Schlüter KD; Tillmanns H; Piper HM; Reusch HP; Ladilov Y
J Cell Mol Med; 2011 Nov; 15(11):2478-85. PubMed ID: 21199327
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial ATP synthase is a negative regulator of the mitochondrial permeability transition pore.
Pekson R; Liang FG; Axelrod JL; Lee J; Qin D; Wittig AJH; Paulino VM; Zheng M; Peixoto PM; Kitsis RN
Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2303713120. PubMed ID: 38091291
[TBL] [Abstract][Full Text] [Related]
8. The cardioprotectant 3',4'-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats.
Woodman OL; Long R; Pons S; Eychenne N; Berdeaux A; Morin D
Pharmacol Res; 2014 Mar; 81():26-33. PubMed ID: 24521796
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F
Morciano G; Preti D; Pedriali G; Aquila G; Missiroli S; Fantinati A; Caroccia N; Pacifico S; Bonora M; Talarico A; Morganti C; Rizzo P; Ferrari R; Wieckowski MR; Campo G; Giorgi C; Trapella C; Pinton P
J Med Chem; 2018 Aug; 61(16):7131-7143. PubMed ID: 30060655
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilin D and myocardial ischemia-reperfusion injury: a fresh perspective.
Alam MR; Baetz D; Ovize M
J Mol Cell Cardiol; 2015 Jan; 78():80-9. PubMed ID: 25281838
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.
Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA
J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.
Chen Q; Xu H; Xu A; Ross T; Bowler E; Hu Y; Lesnefsky EJ
PLoS One; 2015; 10(3):e0118834. PubMed ID: 25756500
[TBL] [Abstract][Full Text] [Related]
13. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion.
Loor G; Kondapalli J; Iwase H; Chandel NS; Waypa GB; Guzy RD; Vanden Hoek TL; Schumacker PT
Biochim Biophys Acta; 2011 Jul; 1813(7):1382-94. PubMed ID: 21185334
[TBL] [Abstract][Full Text] [Related]
15. The role of mitochondria in protection of the heart by preconditioning.
Halestrap AP; Clarke SJ; Khaliulin I
Biochim Biophys Acta; 2007 Aug; 1767(8):1007-31. PubMed ID: 17631856
[TBL] [Abstract][Full Text] [Related]
16. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
[TBL] [Abstract][Full Text] [Related]
17. The mitochondrial permeability transition pore as a target of cardioprotective signaling.
Baines CP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H903-4. PubMed ID: 17513492
[No Abstract] [Full Text] [Related]
18. The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.
Halestrap AP; Richardson AP
J Mol Cell Cardiol; 2015 Jan; 78():129-41. PubMed ID: 25179911
[TBL] [Abstract][Full Text] [Related]
19. The mitochondrial permeability transition pore and ischemia-reperfusion injury.
Baines CP
Basic Res Cardiol; 2009 Mar; 104(2):181-8. PubMed ID: 19242640
[TBL] [Abstract][Full Text] [Related]
20. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion.
Schriewer JM; Peek CB; Bass J; Schumacker PT
J Am Heart Assoc; 2013 Apr; 2(2):e000159. PubMed ID: 23598272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
